Skip to main content
European Commission logo print header

Capitalising Notch Biomarkers in the Drug Development Market

Cel

"CapNotch is the translation from discovery of multimodal cancer biomarkers of the Notch pathway to a strong market proposition. Biomarker products for validating specificity, efficacy and toxicity of preclinical compounds that target this pathway are highly wanted by academia and industry and could fuel progress in this area. One step further lays the opportunity to exploit such biomarkers for patient stratification and treatment monitoring, as well for advancing clinical trials as for supporting clinical decision making. The outcome of CapNotch should guide the selection of the most feasible proposition."

Zaproszenie do składania wniosków

ERC-2012-PoC
Zobacz inne projekty w ramach tego zaproszenia

Instytucja przyjmująca

UNIVERSITEIT MAASTRICHT
Wkład UE
€ 150 000,00
Adres
MINDERBROEDERSBERG 4
6200 MD Maastricht
Niderlandy

Zobacz na mapie

Region
Zuid-Nederland Limburg (NL) Zuid-Limburg
Rodzaj działalności
Higher or Secondary Education Establishments
Kontakt administracyjny
Judith Doomen (Ms.)
Linki
Koszt całkowity
Brak danych

Beneficjenci (1)